Oxxon Therapeutics Inc. Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
1/21/2010 8:57:01 AM
More...
|
Oxxon Therapeutics Inc. to be Acquired by Oxford BioMedica PLC (OXB.L) for GBP 16 Million
3/12/2007 8:36:12 AM
More...
|
Oxxon Therapeutics Inc.' Hi-8(TM) MEL Therapeutic Vaccine Demonstrates Potential For Treatment Of Advanced Metastatic Melanoma
6/6/2006 11:27:21 AM
More...
|
Oxxon Therapeutics Inc. To Present Phase IIA Survival Data For Its HI-8(TM) Mel Therapeutic Vaccine As A Treatment For Advanced Metastatic Melanoma
5/30/2006 10:22:14 AM
More...
|
Oxxon Therapeutics Inc. HI-8(TM) HBV Therapeutic Vaccine Proves Safe And Efficacious In Treating Chronic Hepatitis B
4/27/2006 1:18:41 PM
More...
|
Oxxon Therapeutics Inc. Appoints Craig R. Smith, M.D. Chairman And John Berriman Executive Deputy Chairman Of Its Board Of Directors
4/11/2006 11:16:59 AM
More...
|
Oxxon Therapeutics Inc. Reports Positive Preliminary Phase IIa Data With Chronic Hepatitis B Therapeutic Vaccine
11/11/2005 10:44:43 AM
More...
|
Xenova Group PLC (XNVA) Licenses DISC-HSV And DISC-GM-CSF Vector Technologies To Oxxon Therapeutics Inc.; $83 Million; Stock Up
10/19/2005 5:12:16 PM
More...
|
Oxxon Therapeutics Inc. Announces The Promotion Of Dr. Mark Payton To Vice President Of Corporate Development
10/19/2005 5:10:58 PM
More...
|
Oxxon Therapeutics Ltd Launches U.S. Operation And Announces New Name
10/19/2005 5:10:52 PM
More...
|
|